Ramirez Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Ramirez Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1K	Hold	216	–	–	﹤0.01%	296
2025 Q4	$11.7K	Sell	216 -700	-76%	-$33.7K	﹤0.01%	334
2025 Q3	$41.3K	Hold	916	–	–	0.01%	295
2025 Q2	$42.4K	Sell	916 -200	-18%	-$9.82K	0.01%	287
2025 Q1	$68.1K	Sell	1,116 -400	-26%	-$23.3K	0.01%	275
2024 Q4	$85.7K	Hold	1,516	–	–	0.02%	266
2024 Q3	$78.4K	Sell	1,516 -400	-21%	-$18.8K	0.02%	277
2024 Q2	$79.6K	Hold	1,916	–	–	0.02%	281
2024 Q1	$104K	Sell	1,916 -17,798	-90%	-$907K	0.02%	271
2023 Q4	$1.01M	Hold	19,714	–	–	0.21%	131
2023 Q3	$1.14M	Buy	+19,714	New	+$1.21M	0.25%	115

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ramirez Asset Management's BMY Position: Q1 2026 in Review

Ramirez Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 216 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Ramirez Asset Management first reported a position in BMY in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.14M in Q3 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Ramirez Asset Management held 216 shares of Bristol-Myers Squibb worth $13.1K as of Q1 2026.
Ramirez Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up ﹤0.01% of Ramirez Asset Management's portfolio in Q1 2026, its #296 holding.
Ramirez Asset Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 11 quarters since.
Ramirez Asset Management's Bristol-Myers Squibb position peaked at $1.14M in Q3 2023.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Ramirez Asset Management's 13F filing for Q1 2026, filed 12 May 2026.